Overview

Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

Clofarabine is a new chemotherapy drug which was FDA approved for the treatment of acute lymphocytic leukemia in children. This study is being done to see if Clofarabine works in adult patients with B-cell types of lymphoma. This research is being done to develop new treatments for patients with lymphoma whose cancer has returned or resisted treatment with previous chemotherapy.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Collaborator:

Genzyme, a Sanofi Company

Treatments:

Clofarabine